Good Products, a leading provider of Enterprise Content Management (ECM) solutions for the pharmaceutical and biopharmaceutical industries, announces the availability of its new Validation Project Management tool ValMan.
Good Products Launches ValMan™to Facilitate Validation Project Management
(12 August, 2008) Good Products, a leading provider of Enterprise Content Management (ECM) solutions for the pharmaceutical and biopharmaceutical industries, announces the availability of its new Validation Project Management tool ValMan™. This unique software helps life sciences organizations to store and manage validation protocols and test plans, enabling compliance with the strict regulations governing the industry. ValMan™ is available as part of the g-docs™ suite which is designed to streamline document management. A free of charge demo can be accessed via ValMan@goodproductsEU.com
Within the life sciences industry, multiple validation systems have traditionally been used to manage validation documents and projects, with individual templates being created for each project. Companies are now finding these processes extremely time-consuming and costly, and are looking for more streamlined and cohesive alternatives. Good Products has developed ValMan™ to provide a cost-effective, practical and complete validation project management system, and as the regulations and requirements change then protocols, templates and master plans are updated automatically.
ValMan™ enhances Good Products’ existing portfolio of eDMS solutions, which offer organizations regulatory-compliant, effective and easy-to-use methods of tracking documents and managing approvals. ValMan™ allows users to manage multiple validation projects in a clear and organized format, with the status of each of the products visible on a high level portfolio page.
The ValMan™ software tool allows documents and activities for specific projects to be stored in separate secure areas, while a set of predetermined workflow templates facilitates effective project management. Version control of all documents is carried out within ValMan™ and approved documents are published to a separate library for added user convenience. Product training is minimal as users are already familiar with the web browser environment of the g-docs™ platform and once ValMan™ is implemented, administrators control the ability to configure future libraries, templates and workflows.
ValMan™ customers can choose from a database of over 5,000 validation template documents covering facilities, cleaning, manufacturing equipment, laboratory equipment and computerized systems for biopharma, laboratory and clinical organizations to pre-populate their validation document libraries. ValMan™ also contains pre-configured project workflows, although companies’ existing templates, responsibility matrices, protocol review and approval workflows can also be entered quickly into the system. Within ValMan™, documents are stored on the g-docs™ MOSS 2007 platform and can be easily integrated with existing software systems, such as training management and learning management systems. Electronic documents and protocol deviation forms can be easily digitally signed using the CoSign® digital signature solution.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.